ReviewTurkish journal of orthodontics2019
Alternate Rapid Maxillary Expansion and Constriction (Alt-RAMEC) protocol: A Comprehensive Literature Review.
Review in Turkish journal of orthodontics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 27 citations in OpenAlex.
- The sutural and dentoskeletal effects of alternate expansion and constriction of deficient maxilla in young adults: a randomized controlled clinical trial.BMC oral health · 2025Trial
- Treatment of skeletal class III malocclusion with the Alt-RAMEC protocol and intermaxillary elastics : A retrospective cohort study.Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie · 2026Article
- Comparative analysis of rapid expansion combined with maxillary protraction therapy in patients at different growth phases: A retrospective study.Experimental and therapeutic medicine · 2025Article
- Comparative Analysis of Early Class III Malocclusion Treatments-A Systematic Review and Meta-Analysis.Children (Basel, Switzerland) · 2025Review
- READER'S FORUM.Korean journal of orthodontics · 2025Article
- Soft tissue evaluation after maxillary protraction with RPE or with the ALT-RAMEC protocol : A controlled 3D study.Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie · 2023Article
- Effects of Alt-RAMEC protocol with facemask therapy in cleft lip palate patients in a sample of Pakistani population.BMC oral health · 2023Article
- Correction of late adolescent skeletal Class III using the Alt-RAMEC protocol and skeletal anchorage.Korean journal of orthodontics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this comprehensive review is to introduce clinicians to the increasingly popularity Alt-RAMEC procedure, a method commonly used in the treatment of class III malocclusion in the last 15 years. Another application of the literature to enhance the skeletal effects of Class III treatment on the maxillae is the Alternative Rapid Maxillary Expansion and Constriction (Alt-RAMEC) procedure introduced by Liou, which improves the effectiveness of the maxillae relative to the surrounding sutures and the enhancement of the maxillae. In the Alt-RAMEC protocol, maxillae will be enlarged to be 1 mm per day, first enlarged to 7 mm, and then the 1 mm screw is closed. In other weeks, in this order the screw of the expansion device is turned on for one week and then closed for one week, completing the Alt-RAMEC protocol at the end of the 9-week process. In this review, we will discuss the advantages and disadvantages of the studies, which include successful treatments by applying this protocol, differences with other methods, its effect on the airway, and its advantages and disadvantages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.